Kalofonos Isabel 4
4 · ImmunoGen, Inc. · Filed May 2, 2023
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Kalofonos Isabel
SVP & CHIEF COMMERCIAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2023-04-28+284,250→ 284,250 totalExercise: $5.39Exp: 2033-04-28→ Common Stock (284,250 underlying) - Award
Restricted Stock Unit
2023-04-28+47,375→ 47,375 totalExercise: $0.00→ Common Stock (47,375 underlying)
Footnotes (3)
- [F1]These options vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant, subject to continued service through each vesting date.
- [F2]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F3]The RSUs vest over a four-year period, with 25% of the RSUs vesting on each of the first four anniversaries of the date of grant, subject to continued service through each vesting date.